Global Prescription Drugs Market Overview

Prescription Drugs Market size is projected to reach xxxx units by 2025 from an estimated xxxx unit in 2019, growing at a CAGR of xx% globally.

Introspective Market Research provides the newest industry data about Prescription Drugs Market and industry future trends, allowing you to identify the products and end users driving revenue growth and profitability. The Prescription Drugs industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market.

Scope of the Prescription Drugs Market

The main goal of this report is to help users understand the Prescription Drugs market in terms of its definition, segmentation, market potential, influential trends, and challenges facing the market. In-depth research and analysis took place while preparing the report. Readers will find this report very helpful to in-depth understanding of the market.

Market Segmentation



Players Covered in Prescription Drugs market are :

  • Novartis AG
  • Pfizer
  • Inc.
  • Hoffmann-La Roche Ltd
  • Sanofi
  • Johnson & Johnson Services
  • Inc
  • Merck & Co.
  • Inc.
  • AbbVie
  • Inc.
  • GlaxoSmithKline plc.
  • AstraZeneca
  • CELGENE CORPORATION (BRISTOL-MYERS
  • QUIBB COMPANY)
  • Others

Prescription Drugs Market - Global Size & Upcoming Industry Trends
Segmentations by Type
  • Generics
  • Orphan
  • and Other Prescription Drugs
by Application
  • Hospital Pharmacies
  • Retail Pharmacies & Drug Stores
  • and Online Pharmacies
by Region
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Southeast Asia, Rest of APAC)
  • Middle East & Africa (GCC Countries, South Africa, Rest of MEA)
  • South America (Brazil, Argentina, Rest of South America)
Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Type
 3.2 By Application

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  3.5.1 Drivers
  3.5.2 Restraints
  3.5.3 Opportunities
  3.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 4: Prescription Drugs Market by Type
 4.1 Prescription Drugs Market Overview Snapshot and Growth Engine
 4.2 Prescription Drugs Market Overview
 4.3 Generics
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size (2016-2028F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Generics: Grographic Segmentation
 4.4 Orphan
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size (2016-2028F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Orphan: Grographic Segmentation
 4.5 and Other Prescription Drugs
  4.5.1 Introduction and Market Overview
  4.5.2 Historic and Forecasted Market Size (2016-2028F)
  4.5.3 Key Market Trends, Growth Factors and Opportunities
  4.5.4 and Other Prescription Drugs: Grographic Segmentation

Chapter 5: Prescription Drugs Market by Application
 5.1 Prescription Drugs Market Overview Snapshot and Growth Engine
 5.2 Prescription Drugs Market Overview
 5.3 Hospital Pharmacies
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Hospital Pharmacies: Grographic Segmentation
 5.4 Retail Pharmacies & Drug Stores
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Retail Pharmacies & Drug Stores: Grographic Segmentation
 5.5 and Online Pharmacies
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2016-2028F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 and Online Pharmacies: Grographic Segmentation

Chapter 6: Company Profiles and Competitive Analysis
 6.1 Competitive Landscape
  6.1.1 Competitive Positioning
  6.1.2 Prescription Drugs Sales and Market Share By Players
  6.1.3 Industry BCG Matrix
  6.1.4 Ansoff Matrix
  6.1.5 Prescription Drugs Industry Concentration Ratio (CR5 and HHI)
  6.1.6 Top 5 Prescription Drugs Players Market Share
  6.1.7 Mergers and Acquisitions
  6.1.8 Business Strategies By Top Players
 6.2 NOVARTIS AG
  6.2.1 Company Overview
  6.2.2 Key Executives
  6.2.3 Company Snapshot
  6.2.4 Operating Business Segments
  6.2.5 Product Portfolio
  6.2.6 Business Performance
  6.2.7 Key Strategic Moves and Recent Developments
  6.2.8 SWOT Analysis
 6.3 PFIZER
 6.4 INC.
 6.5 HOFFMANN-LA ROCHE LTD
 6.6 SANOFI
 6.7 JOHNSON & JOHNSON SERVICES
 6.8 INC
 6.9 MERCK & CO.
 6.10 INC.
 6.11 ABBVIE
 6.12 INC.
 6.13 GLAXOSMITHKLINE PLC.
 6.14 ASTRAZENECA
 6.15 CELGENE CORPORATION (BRISTOL-MYERS
 6.16 QUIBB COMPANY)
 6.17 OTHERS

Chapter 7: Global Prescription Drugs Market Analysis, Insights and Forecast, 2016-2028
 7.1 Market Overview
 7.2 Historic and Forecasted Market Size By Type
  7.2.1 Generics
  7.2.2 Orphan
  7.2.3 and Other Prescription Drugs
 7.3 Historic and Forecasted Market Size By Application
  7.3.1 Hospital Pharmacies
  7.3.2 Retail Pharmacies & Drug Stores
  7.3.3 and Online Pharmacies

Chapter 8: North America Prescription Drugs Market Analysis, Insights and Forecast, 2016-2028
 8.1 Key Market Trends, Growth Factors and Opportunities
 8.2 Impact of Covid-19
 8.3 Key Players
 8.4 Key Market Trends, Growth Factors and Opportunities
 8.4 Historic and Forecasted Market Size By Type
  8.4.1 Generics
  8.4.2 Orphan
  8.4.3 and Other Prescription Drugs
 8.5 Historic and Forecasted Market Size By Application
  8.5.1 Hospital Pharmacies
  8.5.2 Retail Pharmacies & Drug Stores
  8.5.3 and Online Pharmacies
 8.6 Historic and Forecast Market Size by Country
  8.6.1 U.S.
  8.6.2 Canada
  8.6.3 Mexico

Chapter 9: Europe Prescription Drugs Market Analysis, Insights and Forecast, 2016-2028
 9.1 Key Market Trends, Growth Factors and Opportunities
 9.2 Impact of Covid-19
 9.3 Key Players
 9.4 Key Market Trends, Growth Factors and Opportunities
 9.4 Historic and Forecasted Market Size By Type
  9.4.1 Generics
  9.4.2 Orphan
  9.4.3 and Other Prescription Drugs
 9.5 Historic and Forecasted Market Size By Application
  9.5.1 Hospital Pharmacies
  9.5.2 Retail Pharmacies & Drug Stores
  9.5.3 and Online Pharmacies
 9.6 Historic and Forecast Market Size by Country
  9.6.1 Germany
  9.6.2 U.K.
  9.6.3 France
  9.6.4 Italy
  9.6.5 Russia
  9.6.6 Spain

Chapter 10: Asia-Pacific Prescription Drugs Market Analysis, Insights and Forecast, 2016-2028
 10.1 Key Market Trends, Growth Factors and Opportunities
 10.2 Impact of Covid-19
 10.3 Key Players
 10.4 Key Market Trends, Growth Factors and Opportunities
 10.4 Historic and Forecasted Market Size By Type
  10.4.1 Generics
  10.4.2 Orphan
  10.4.3 and Other Prescription Drugs
 10.5 Historic and Forecasted Market Size By Application
  10.5.1 Hospital Pharmacies
  10.5.2 Retail Pharmacies & Drug Stores
  10.5.3 and Online Pharmacies
 10.6 Historic and Forecast Market Size by Country
  10.6.1 China
  10.6.2 India
  10.6.3 Japan
  10.6.4 Southeast Asia

Chapter 11: South America Prescription Drugs Market Analysis, Insights and Forecast, 2016-2028
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Type
  11.4.1 Generics
  11.4.2 Orphan
  11.4.3 and Other Prescription Drugs
 11.5 Historic and Forecasted Market Size By Application
  11.5.1 Hospital Pharmacies
  11.5.2 Retail Pharmacies & Drug Stores
  11.5.3 and Online Pharmacies
 11.6 Historic and Forecast Market Size by Country
  11.6.1 Brazil
  11.6.2 Argentina

Chapter 12: Middle East & Africa Prescription Drugs Market Analysis, Insights and Forecast, 2016-2028
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Type
  12.4.1 Generics
  12.4.2 Orphan
  12.4.3 and Other Prescription Drugs
 12.5 Historic and Forecasted Market Size By Application
  12.5.1 Hospital Pharmacies
  12.5.2 Retail Pharmacies & Drug Stores
  12.5.3 and Online Pharmacies
 12.6 Historic and Forecast Market Size by Country
  12.6.1 Saudi Arabia
  12.6.2 South Africa

Chapter 13 Investment Analysis

Chapter 14 Analyst Viewpoint and Conclusion
Prescription Drugs Market - Global Size & Upcoming Industry Trends
Segmentations by Type
  • Generics
  • Orphan
  • and Other Prescription Drugs
by Application
  • Hospital Pharmacies
  • Retail Pharmacies & Drug Stores
  • and Online Pharmacies
by Region
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Southeast Asia, Rest of APAC)
  • Middle East & Africa (GCC Countries, South Africa, Rest of MEA)
  • South America (Brazil, Argentina, Rest of South America)
LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. PRESCRIPTION DRUGS MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. PRESCRIPTION DRUGS MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. PRESCRIPTION DRUGS MARKET COMPETITIVE RIVALRY
TABLE 005. PRESCRIPTION DRUGS MARKET THREAT OF NEW ENTRANTS
TABLE 006. PRESCRIPTION DRUGS MARKET THREAT OF SUBSTITUTES
TABLE 007. PRESCRIPTION DRUGS MARKET BY TYPE
TABLE 008. GENERICS MARKET OVERVIEW (2016-2028)
TABLE 009. ORPHAN MARKET OVERVIEW (2016-2028)
TABLE 010. AND OTHER PRESCRIPTION DRUGS MARKET OVERVIEW (2016-2028)
TABLE 011. PRESCRIPTION DRUGS MARKET BY APPLICATION
TABLE 012. HOSPITAL PHARMACIES MARKET OVERVIEW (2016-2028)
TABLE 013. RETAIL PHARMACIES & DRUG STORES MARKET OVERVIEW (2016-2028)
TABLE 014. AND ONLINE PHARMACIES MARKET OVERVIEW (2016-2028)
TABLE 015. NORTH AMERICA PRESCRIPTION DRUGS MARKET, BY TYPE (2016-2028)
TABLE 016. NORTH AMERICA PRESCRIPTION DRUGS MARKET, BY APPLICATION (2016-2028)
TABLE 017. N PRESCRIPTION DRUGS MARKET, BY COUNTRY (2016-2028)
TABLE 018. EUROPE PRESCRIPTION DRUGS MARKET, BY TYPE (2016-2028)
TABLE 019. EUROPE PRESCRIPTION DRUGS MARKET, BY APPLICATION (2016-2028)
TABLE 020. PRESCRIPTION DRUGS MARKET, BY COUNTRY (2016-2028)
TABLE 021. ASIA PACIFIC PRESCRIPTION DRUGS MARKET, BY TYPE (2016-2028)
TABLE 022. ASIA PACIFIC PRESCRIPTION DRUGS MARKET, BY APPLICATION (2016-2028)
TABLE 023. PRESCRIPTION DRUGS MARKET, BY COUNTRY (2016-2028)
TABLE 024. MIDDLE EAST & AFRICA PRESCRIPTION DRUGS MARKET, BY TYPE (2016-2028)
TABLE 025. MIDDLE EAST & AFRICA PRESCRIPTION DRUGS MARKET, BY APPLICATION (2016-2028)
TABLE 026. PRESCRIPTION DRUGS MARKET, BY COUNTRY (2016-2028)
TABLE 027. SOUTH AMERICA PRESCRIPTION DRUGS MARKET, BY TYPE (2016-2028)
TABLE 028. SOUTH AMERICA PRESCRIPTION DRUGS MARKET, BY APPLICATION (2016-2028)
TABLE 029. PRESCRIPTION DRUGS MARKET, BY COUNTRY (2016-2028)
TABLE 030. NOVARTIS AG: SNAPSHOT
TABLE 031. NOVARTIS AG: BUSINESS PERFORMANCE
TABLE 032. NOVARTIS AG: PRODUCT PORTFOLIO
TABLE 033. NOVARTIS AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 033. PFIZER: SNAPSHOT
TABLE 034. PFIZER: BUSINESS PERFORMANCE
TABLE 035. PFIZER: PRODUCT PORTFOLIO
TABLE 036. PFIZER: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 036. INC.: SNAPSHOT
TABLE 037. INC.: BUSINESS PERFORMANCE
TABLE 038. INC.: PRODUCT PORTFOLIO
TABLE 039. INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 039. HOFFMANN-LA ROCHE LTD: SNAPSHOT
TABLE 040. HOFFMANN-LA ROCHE LTD: BUSINESS PERFORMANCE
TABLE 041. HOFFMANN-LA ROCHE LTD: PRODUCT PORTFOLIO
TABLE 042. HOFFMANN-LA ROCHE LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 042. SANOFI: SNAPSHOT
TABLE 043. SANOFI: BUSINESS PERFORMANCE
TABLE 044. SANOFI: PRODUCT PORTFOLIO
TABLE 045. SANOFI: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 045. JOHNSON & JOHNSON SERVICES: SNAPSHOT
TABLE 046. JOHNSON & JOHNSON SERVICES: BUSINESS PERFORMANCE
TABLE 047. JOHNSON & JOHNSON SERVICES: PRODUCT PORTFOLIO
TABLE 048. JOHNSON & JOHNSON SERVICES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 048. INC: SNAPSHOT
TABLE 049. INC: BUSINESS PERFORMANCE
TABLE 050. INC: PRODUCT PORTFOLIO
TABLE 051. INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 051. MERCK & CO.: SNAPSHOT
TABLE 052. MERCK & CO.: BUSINESS PERFORMANCE
TABLE 053. MERCK & CO.: PRODUCT PORTFOLIO
TABLE 054. MERCK & CO.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 054. INC.: SNAPSHOT
TABLE 055. INC.: BUSINESS PERFORMANCE
TABLE 056. INC.: PRODUCT PORTFOLIO
TABLE 057. INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 057. ABBVIE: SNAPSHOT
TABLE 058. ABBVIE: BUSINESS PERFORMANCE
TABLE 059. ABBVIE: PRODUCT PORTFOLIO
TABLE 060. ABBVIE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 060. INC.: SNAPSHOT
TABLE 061. INC.: BUSINESS PERFORMANCE
TABLE 062. INC.: PRODUCT PORTFOLIO
TABLE 063. INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 063. GLAXOSMITHKLINE PLC.: SNAPSHOT
TABLE 064. GLAXOSMITHKLINE PLC.: BUSINESS PERFORMANCE
TABLE 065. GLAXOSMITHKLINE PLC.: PRODUCT PORTFOLIO
TABLE 066. GLAXOSMITHKLINE PLC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 066. ASTRAZENECA: SNAPSHOT
TABLE 067. ASTRAZENECA: BUSINESS PERFORMANCE
TABLE 068. ASTRAZENECA: PRODUCT PORTFOLIO
TABLE 069. ASTRAZENECA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 069. CELGENE CORPORATION (BRISTOL-MYERS: SNAPSHOT
TABLE 070. CELGENE CORPORATION (BRISTOL-MYERS: BUSINESS PERFORMANCE
TABLE 071. CELGENE CORPORATION (BRISTOL-MYERS: PRODUCT PORTFOLIO
TABLE 072. CELGENE CORPORATION (BRISTOL-MYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 072. QUIBB COMPANY): SNAPSHOT
TABLE 073. QUIBB COMPANY): BUSINESS PERFORMANCE
TABLE 074. QUIBB COMPANY): PRODUCT PORTFOLIO
TABLE 075. QUIBB COMPANY): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 075. OTHERS: SNAPSHOT
TABLE 076. OTHERS: BUSINESS PERFORMANCE
TABLE 077. OTHERS: PRODUCT PORTFOLIO
TABLE 078. OTHERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. PRESCRIPTION DRUGS MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. PRESCRIPTION DRUGS MARKET OVERVIEW BY TYPE
FIGURE 012. GENERICS MARKET OVERVIEW (2016-2028)
FIGURE 013. ORPHAN MARKET OVERVIEW (2016-2028)
FIGURE 014. AND OTHER PRESCRIPTION DRUGS MARKET OVERVIEW (2016-2028)
FIGURE 015. PRESCRIPTION DRUGS MARKET OVERVIEW BY APPLICATION
FIGURE 016. HOSPITAL PHARMACIES MARKET OVERVIEW (2016-2028)
FIGURE 017. RETAIL PHARMACIES & DRUG STORES MARKET OVERVIEW (2016-2028)
FIGURE 018. AND ONLINE PHARMACIES MARKET OVERVIEW (2016-2028)
FIGURE 019. NORTH AMERICA PRESCRIPTION DRUGS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 020. EUROPE PRESCRIPTION DRUGS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 021. ASIA PACIFIC PRESCRIPTION DRUGS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 022. MIDDLE EAST & AFRICA PRESCRIPTION DRUGS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 023. SOUTH AMERICA PRESCRIPTION DRUGS MARKET OVERVIEW BY COUNTRY (2016-2028)
Please Wait...

Frequently Asked Questions :

What would be forecast period in the market research report?
The forecast period in the market research report is 2021-2027.
Who are the key players in Prescription Drugs market?
The key players mentioned are Novartis AG, Pfizer, Inc., Hoffmann-La Roche Ltd, Sanofi, Johnson & Johnson Services, Inc, Merck & Co., Inc., AbbVie, Inc., GlaxoSmithKline plc., AstraZeneca, CELGENE CORPORATION (BRISTOL-MYERS , QUIBB COMPANY), Others.
What are the segments of Prescription Drugs market?
The Prescription Drugs market is segmented into application type, product type and region. By Application type, the market is categorized into Hospital Pharmacies, Retail Pharmacies & Drug Stores, and Online Pharmacies. By product type, it is classified into Generics, Orphan, and Other Prescription Drugs and others. By region, it is analysed across North America (U.S.; Canada; Mexico), Europe (Germany; U.K.; France; Italy; Russia; Spain etc.), Asia-Pacific (China; India; Japan; Southeast Asia etc.), South America (Brazil; Argentina etc.), Middle East & Africa (Saudi Arabia; South Africa etc.).
What is the Prescription Drugs market?
Prescription Drugs Market size is projected to reach xxxx units by 2027 from an estimated xxxx unit in 2020, growing at a CAGR of xx% globally.
How big is the Prescription Drugs market?
The global Prescription Drugs market size was estimated at USD XX billion in 2020 and is expected to reach USD XX billion in 2027.